Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1,863 | 3 | 89.3% |
| Education | $129.08 | 4 | 6.2% |
| Food and Beverage | $93.49 | 1 | 4.5% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $1,863 | 3 | $0 (2017) |
| Novo Nordisk Inc | $129.08 | 4 | $0 (2020) |
| Apollo Endosurgery US Inc | $93.49 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $93.49 | 1 | Apollo Endosurgery US Inc ($93.49) |
| 2020 | $129.08 | 4 | Novo Nordisk Inc ($129.08) |
| 2017 | $1,863 | 3 | NOVARTIS PHARMACEUTICALS CORPORATION ($1,863) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/24/2022 | Apollo Endosurgery US Inc | OverStitch Endoscopic Suturing System (Device), ORBERA Intragastric Balloon System | Food and Beverage | In-kind items and services | $93.49 | General |
| Category: ENDOSCOPIC TISSUE APPROXIMATION DEVICE | ||||||
| 06/04/2020 | Novo Nordisk Inc | Saxenda (Drug) | Education | In-kind items and services | $32.27 | General |
| Category: Obesity | ||||||
| 03/13/2020 | Novo Nordisk Inc | — | Education | In-kind items and services | $32.27 | General |
| 03/12/2020 | Novo Nordisk Inc | Saxenda (Drug) | Education | In-kind items and services | $32.27 | General |
| Category: Obesity | ||||||
| 03/12/2020 | Novo Nordisk Inc | Saxenda (Drug) | Education | In-kind items and services | $32.27 | General |
| Category: Obesity | ||||||
| 04/02/2017 | NOVARTIS PHARMACEUTICALS CORPORATION | SIGNIFOR (Drug) | — | In-kind items and services | $418.94 | Research |
| Study: RESEARCH RELATED PUBLICATION SUPPORT • Category: ONCOLOGY | ||||||
| 04/02/2017 | NOVARTIS PHARMACEUTICALS CORPORATION | SIGNIFOR (Drug) | — | In-kind items and services | $335.15 | Research |
| Study: RESEARCH RELATED PUBLICATION SUPPORT • Category: ONCOLOGY | ||||||
| 01/11/2017 | NOVARTIS PHARMACEUTICALS CORPORATION | SIGNIFOR (Drug) | — | In-kind items and services | $1,108.82 | Research |
| Study: RESEARCH RELATED PUBLICATION SUPPORT • Category: ONCOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| RESEARCH RELATED PUBLICATION SUPPORT | NOVARTIS PHARMACEUTICALS CORPORATION | $1,863 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 290 | 425 | $404,299 | $48,459 |
| 2022 | 5 | 210 | 267 | $248,331 | $27,082 |
| 2021 | 6 | 343 | 504 | $427,517 | $46,986 |
| 2020 | 7 | 197 | 309 | $155,057 | $20,102 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 40 | 96 | $92,160 | $11,656 | 12.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 47 | 76 | $65,208 | $8,254 | 12.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 44 | 75 | $64,350 | $5,927 | 9.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 27 | 27 | $36,720 | $5,020 | 13.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 28 | $26,880 | $4,186 | 15.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $28,210 | $3,738 | 13.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 25 | 25 | $34,000 | $3,724 | 11.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 35 | 35 | $37,975 | $3,714 | 9.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 18 | $9,144 | $1,335 | 14.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 14 | 19 | $9,652 | $905.92 | 9.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 40 | 61 | $58,560 | $7,291 | 12.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 47 | 65 | $55,770 | $4,747 | 8.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 28 | 28 | $38,080 | $4,444 | 11.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 18 | 24 | $20,592 | $2,638 | 12.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 13 | 13 | $17,680 | $2,353 | 13.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 22 | 22 | $23,870 | $2,201 | 9.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 31 | 43 | $21,844 | $1,860 | 8.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $11,935 | $1,550 | 13.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 103 | 171 | $146,718 | $13,963 | 9.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 49 | 92 | $88,320 | $11,513 | 13.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 72 | 72 | $78,120 | $8,092 | 10.4% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 41 | 41 | $55,760 | $6,440 | 11.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 64 | 110 | $56,457 | $6,153 | 10.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 14 | 18 | $2,142 | $825.30 | 38.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 54 | 104 | $59,280 | $6,726 | 11.3% |
About Dr. Vijaya Surampudi, M.D
Dr. Vijaya Surampudi, M.D is a Internal Medicine healthcare provider based in Torrance, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/08/2010. The National Provider Identifier (NPI) number assigned to this provider is 1346566916.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vijaya Surampudi, M.D has received a total of $2,085 in payments from pharmaceutical and medical device companies, with $93.49 received in 2022. These payments were reported across 8 transactions from 3 companies. The most common payment nature is "" ($1,863).
As a Medicare-enrolled provider, Surampudi has provided services to 1,040 Medicare beneficiaries, totaling 1,505 services with total Medicare billing of $142,629. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Diabetes & Metabolism
- Location Torrance, CA
- Active Since 04/08/2010
- Last Updated 12/12/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1346566916
Products in Payments
- SIGNIFOR (Drug) $1,863
- Saxenda (Drug) $96.81
- OverStitch Endoscopic Suturing System (Device) $93.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Torrance
Catherine Oberg, M.d, M.D
Internal Medicine — Payments: $307,633
Dr. Robert Jenders
Internal Medicine — Payments: $158,314
Vivek Gupta, M.d, M.D
Internal Medicine — Payments: $47,609
Dr. Sofiya Reicher, Md, MD
Internal Medicine — Payments: $41,778
Dr. Zonglang Tsai, M.d, M.D
Internal Medicine — Payments: $29,124
Khalid Eltawil, Md, MD
Internal Medicine — Payments: $25,608